Atlas Trials

Locally Recurrent and Metastatic Breast Cancer

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Recurrent and Metastatic Breast Cancer

RecordFirmDate
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer (NCT00807859)Amgen2009-03-09
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients (NCT00511459)Amgen2007-07-01
A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer (NCT00356681)Amgen2006-12-01
Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer (NCT00322400)Amgen2006-03-01

Track Locally Recurrent and Metastatic Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.